SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Abgenix, Inc. (ABGX) -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (354)8/3/2004 2:39:50 AM
From: tuck  Read Replies (2) | Respond to of 590
 
>>Isn't the IMCL patent claim anti-EGFr in combo with chemo? Isn't that what MZ was emphasizing?<<

Yes. Someone -- Erik? -- said they'd be surprised if it held up, given its broadness, but that someone was not a patent attorney.

I'd forgotten MZ was in Croatia. At least Wilder has reappeared.

Cheers, Tuck